Who is sponsoring NCT05971134?

NCT05971134 is sponsored by Baskent University.

What drugs are being tested in NCT05971134?

Interventions in NCT05971134: Acupreesure applied.

What condition does NCT05971134 study?

NCT05971134 studies Chronic Kidney Disease Stage 5 (Disorder).

Is NCT05971134 still recruiting?

NCT05971134 is currently completed. Last updated 2 August 2023.

Last reviewed 2023-08-02 · How we verify

NCT05971134

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acupressure and Fistula Needle Insert Pain Management

Completed NA Last updated 2 August 2023

What this trial tests

NA trial testing Acupreesure applied in Chronic Kidney Disease Stage 5 (Disorder) in 131 participants. Completed in 1 July 2023.

Timeline

1 October 2022

Primary endpoint
1 February 2023

1 July 2023

Quick facts

Lead sponsor	Baskent University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	131
Start date	1 October 2022
Primary completion	1 February 2023
Estimated completion	1 July 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Acupreesure applied

Conditions studied

Chronic Kidney Disease Stage 5 (Disorder) — all drugs for Chronic Kidney Disease Stage 5 (Disorder) →

Sponsor

Baskent University

Who can join

Eligibility, any sex, with Chronic Kidney Disease Stage 5 (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: This study was conducted to determine the effectiveness of acupressure application on Hegu (LI4) point on the severity of acute pain caused by fistula needle in patients with brescia-cimino, snuff-box and antecubital fistula. Methods: This study was randomized control study which was conducted with 66 intervention and 65 control participants. The participants in the intervention group were divided into 3 groups according to the fistula area. Data were collected using Descriptive Information Form and pain scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Baskent University trials

Trials by the same sponsor.

NCT07521982 — Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healt · not yet recruiting
NCT07202650 — THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME · NA · recruiting
NCT07394907 — The Effectiveness of Gamified Metaverse-Based Training on Patient Safety for Nursing Students · NA · not yet recruiting
NCT07395284 — The Effect of Gamified Metaverse-Based Training on Nursing Students' Self-Efficacy and Metaverse Perception Regarding Pr · NA · not yet recruiting
NCT07385339 — Comfort Communication Model Intervention for Burn Pain and Pain Anxiety · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05971134 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baskent University
Last refreshed: 2 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05971134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing